Myeloid-derived suppressor cell-targeted virus-like particles synergistically activate innate immune response for cancer immunotherapy
Zhixiong Zhu(Sichuan University), Bin Shao(Sichuan University), Shuqin Cao(Sichuan University), Luxuan Shen(Sichuan University), Nian Yang(Sichuan University), Aiping Tong(Chengdu Medical College), Jiayun Yu(Sichuan University), Zeng Wang(Sichuan University), Hanwen Li(Yangzhou University), Zongliang Zhang(Sichuan University), Hexian Li(Sichuan University), Chunlai Nie(University of Electronic Science and Technology of China), Jianshu Li(China University of Petroleum, Beijing), Meijun Zheng(Sichuan University), Qizhong Lu(Sichuan University)
Cited by 8
Related Papers
B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
|Molecular Therapy — Oncolytics|2019|214
Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors
|Theranostics|2020|184
Development of therapeutic antibodies for the treatment of diseases
|Molecular Biomedicine|2022|125
Extracellular matrix remodeling in the tumor immunity
|Frontiers in Immunology|2024|86